Merck & Co (MRK) earnings per share (EPS)

Earnings per share · fiscal 2025
$7.28

Merck & Co (MRK) reported diluted earnings per share of $7.28 in fiscal 2025 (the year ended December 31, 2025). That is 8.0% higher than the $6.74 of fiscal 2024. Figures as of 17 Nov 2026, 21:51 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$7.28
Change on fiscal 2024
+8.0%
Growth, 5 years
+21.2% a year
Growth, 10 years
+17.2% a year
Highest on record
$7.28fiscal 2025
Lowest on record
$0.14fiscal 2023
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Merck & Co earnings per share (EPS), in more detail

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 21.2% a year; over ten years the rate was 17.2% a year. Across the 19 fiscal years on record (2007–2025), the highest was $7.28 in fiscal 2025 and the lowest $0.14 in fiscal 2023.

History · 19 fiscal years

Earnings per share by fiscal year

Merck & Co earnings per share (EPS), year by year

Merck & Co (MRK) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$7.28 8.0% up
2024$6.74 4,714.3% up
2023$0.14 97.5% down
2022$5.71 11.1% up
2021$5.14 84.9% up
2020$2.78 27.0% down
2019$3.81 72.1% up
2018$2.21 166.7% up
2017$0.83 38.3% down
2016$1.35 9.6% down
2015$1.49 61.7% down
2014$3.88 176.9% up
2013$1.40 26.5% down
2012$1.91 1.0% down
2011$1.93 621.4% up
2010$0.27 95.0% down
2009$5.39 55.6% up
2008$3.46 143.6% up
2007$1.42—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Merck & Co and comparable companies
CompanyEarnings per shareFiscal year
Johnson & Johnson JNJ$11.032025
AbbVie ABBV$2.372025
Merck & Co MRK$7.282025
UnitedHealth Group UNH$13.232025
Novartis NVS$7.152025
AstraZeneca AZN$6.542025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MRK

Merck & Co, figure by figure

Merck & Co (MRK) overview: price, valuation and scorecardAll health care companies by market value

Merck & Co earnings per share (EPS): questions and answers

What is Merck & Co's diluted earnings per share?

Merck & Co (MRK) reported diluted earnings per share of $7.28 in fiscal 2025 (the year ended December 31, 2025). That is 8.0% higher than the $6.74 of fiscal 2024.

What is the growth rate of Merck & Co's diluted earnings per share?

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 21.2% a year; over ten years the rate was 17.2% a year.

What are the highest and lowest diluted earnings per share figures on record for Merck & Co?

Across the 19 fiscal years on record (2007–2025), the highest was $7.28 in fiscal 2025 and the lowest $0.14 in fiscal 2023.

How is Merck & Co's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Merck & Co (MRK) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/MRK/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.